Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OPXA > SEC Filings for OPXA > Form 8-K on 20-Nov-2012All Recent SEC Filings

Show all filings for OPEXA THERAPEUTICS, INC.



Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders for Opexa Therapeutics, Inc. ("Opexa") was held on November 15, 2012 (the "Annual Meeting"). Three proposals were submitted to shareholders as described in the 2012 Proxy Statement and were approved by shareholders at the Annual Meeting. The proposals and the results of the shareholder votes are as follows.

1.                                  For    Withheld Non-Votes
Proposal to elect five directors
for one-year terms:

David E. Jorden                  8,038,220 444,434  8,685,717
Gail J. Maderis                  7,822,155 660,499  8,685,717
Michael S. Richman               8,085,123 397,531  8,685,717
Scott B. Seaman                  7,859,607 623,047  8,685,717
Neil K. Warma                    7,797,742 684,912  8,685,717

2.                                      For      Against  Abstain Non-Votes
Proposal to approve an Amendment
to the Restated Certificate of
Formation to effect a reverse stock
split of Opexa's common
stock, as determined by the Board

of Directors in its discretion, at a ratio of not less than 1-for-2 and not more than 1-for-4 14,663,333 2,373,941 131,097 0

3. For Against Abstain Non-Votes Proposal to ratify the appointment of MaloneBailey, LLP as independent auditors for the fiscal year ending December 31, 2012 16,234,984 625,768 307,619 0

  Add OPXA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OPXA - All Recent SEC Filings
Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.